Pesquisa | Portal de Pesquisa da BVS Enfermagem

1.

Teleocidin B-4, a PKC Activator, Upregulates Hypoxia-Inducible Factor 1 (HIF-1) Activity by Promoting the Accumulation of HIF-1α Protein via the PKCα/mTORC Signaling Pathway.

Iseki, Shogo; Ikeda, Hiroaki; Kobayashi, Sayaka; Irie, Kazuhiro; Harada, Hiroshi; Kakeya, Hideaki.

J Nat Prod ; 2024 Jun 05.

Artigo em Inglês | MEDLINE | ID: mdl-38840407

2.

T cell receptor gene-modified allogeneic T cells with siRNA for endogenous T cell receptor induce efficient tumor regression without graft-versus-host disease.

Okada, Satomi; Muraoka, Daisuke; Yasui, Kiyoshi; Tawara, Isao; Kawamura, Ayumi; Okamoto, Sachiko; Mineno, Junichi; Seo, Naohiro; Shiku, Hiroshi; Eguchi, Susumu; Ikeda, Hiroaki.

Cancer Sci ; 114(11): 4172-4183, 2023 Nov.

Artigo em Inglês | MEDLINE | ID: mdl-37675556

3.

Spin-Derived Electric Polarization and Chirality Density Inherent in Localized Electron Orbitals.

Hoshino, Shintaro; Suzuki, Michi-To; Ikeda, Hiroaki.

Phys Rev Lett ; 130(25): 256801, 2023 Jun 23.

Artigo em Inglês | MEDLINE | ID: mdl-37418743

4.

Current Concepts of Biomaterial Scaffolds and Regenerative Therapy for Spinal Cord Injury.

Suzuki, Hidenori; Imajo, Yasuaki; Funaba, Masahiro; Ikeda, Hiroaki; Nishida, Norihiro; Sakai, Takashi.

Int J Mol Sci ; 24(3)2023 Jan 28.

Artigo em Inglês | MEDLINE | ID: mdl-36768846

5.

Prognostic significance of NY-ESO-1 antigen and PIGR expression in esophageal tumors of CHP-NY-ESO-1-vaccinated patients as adjuvant therapy.

Nagata, Yasuhiro; Kageyama, Shinichi; Ishikawa, Takeshi; Kokura, Satoshi; Okayama, Tetsuya; Abe, Tetsuya; Murakami, Masahiko; Otsuka, Koji; Ariyoshi, Tomotake; Kojima, Takashi; Taniguchi, Ken; Kobayashi, Shinichiro; Shimada, Hideaki; Yajima, Satoshi; Suzuki, Takashi; Hirano, Satoshi; Tsuchikawa, Takahiro; Shichinohe, Toshiaki; Ueda, Shugo; Kanetaka, Kengo; Yoneda, Akira; Wada, Hisashi; Doki, Yuichiro; Yamaue, Hiroki; Katsuda, Masahiro; Ohi, Masaki; Yasuda, Hiromi; Kondo, Ken; Kataoka, Masato; Kodera, Yasuhiro; Koike, Masahiko; Shiraishi, Taizo; Miyahara, Yoshihiro; Goshima, Naoki; Fukuda, Eriko; Yamaguchi, Kei; Sato, Eiichi; Ikeda, Hiroaki; Yamada, Tomomi; Osako, Masaharu; Hirai, Kaoru; Miyamoto, Hiroshi; Watanabe, Takashi; Shiku, Hiroshi.

Cancer Immunol Immunother ; 71(11): 2743-2755, 2022 Nov.

Artigo em Inglês | MEDLINE | ID: mdl-35429246

6.

Design, synthesis, and target identification of new hypoxia-inducible factor 1 (HIF-1) inhibitors containing 1-alkyl-1H-pyrazole-3-carboxamide moiety.

Sakai, Marina; Takahashi, Nobuaki; Ikeda, Hiroaki; Furutani, Yutaka; Higuchi, Shoko; Suzuki, Takehiro; Dohmae, Naoshi; Kobayashi, Sayaka; Harada, Hiroshi; Kojima, Soichi; Matsuura, Tomokazu; Hattori, Akira; Kakeya, Hideaki.

Bioorg Med Chem ; 46: 116375, 2021 09 15.

Artigo em Inglês | MEDLINE | ID: mdl-34492592

7.

CD4⁺ T cells support polyfunctionality of cytotoxic CD8⁺ T cells with memory potential in immunological control of tumor.

Imai, Naoko; Tawara, Isao; Yamane, Makiko; Muraoka, Daisuke; Shiku, Hiroshi; Ikeda, Hiroaki.

Cancer Sci ; 111(6): 1958-1968, 2020 Jun.

Artigo em Inglês | MEDLINE | ID: mdl-32304127

8.

First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors.

Ishihara, Mikiya; Tono, Yasutaka; Miyahara, Yoshihiro; Muraoka, Daisuke; Harada, Naozumi; Kageyama, Shinichi; Sasaki, Takeshi; Hori, Yasuhide; Soga, Norihito; Uchida, Katsunori; Shiraishi, Taizo; Sato, Eiichi; Kanda, Hideki; Mizuno, Toshiro; Webster, Gill A; Ikeda, Hiroaki; Katayama, Naoyuki; Sugimura, Yoshiki; Shiku, Hiroshi.

Cancer Immunol Immunother ; 69(4): 663-675, 2020 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-31980914

9.

Antitumor activity of CAR-T cells targeting the intracellular oncoprotein WT1 can be enhanced by vaccination.

Akahori, Yasushi; Wang, Linan; Yoneyama, Motohiro; Seo, Naohiro; Okumura, Satoshi; Miyahara, Yoshihiro; Amaishi, Yasunori; Okamoto, Sachiko; Mineno, Junichi; Ikeda, Hiroaki; Maki, Takehiro; Fujiwara, Hiroshi; Akatsuka, Yoshiki; Kato, Takuma; Shiku, Hiroshi.

Blood ; 132(11): 1134-1145, 2018 09 13.

Artigo em Inglês | MEDLINE | ID: mdl-30045840

10.

MAGE-A4, NY-ESO-1 and SAGE mRNA expression rates and co-expression relationships in solid tumours.

Ishihara, Mikiya; Kageyama, Shinichi; Miyahara, Yoshihiro; Ishikawa, Takeshi; Ueda, Shugo; Soga, Norihito; Naota, Hiroaki; Mukai, Katsumi; Harada, Naozumi; Ikeda, Hiroaki; Shiku, Hiroshi.

BMC Cancer ; 20(1): 606, 2020 Jun 29.

Artigo em Inglês | MEDLINE | ID: mdl-32600281

11.

Safety and persistence of WT1-specific T-cell receptor gene-transduced lymphocytes in patients with AML and MDS.

Tawara, Isao; Kageyama, Shinichi; Miyahara, Yoshihiro; Fujiwara, Hiroshi; Nishida, Tetsuya; Akatsuka, Yoshiki; Ikeda, Hiroaki; Tanimoto, Kazushi; Terakura, Seitaro; Murata, Makoto; Inaguma, Yoko; Masuya, Masahiro; Inoue, Naoki; Kidokoro, Tomohide; Okamoto, Sachiko; Tomura, Daisuke; Chono, Hideto; Nukaya, Ikuei; Mineno, Junichi; Naoe, Tomoki; Emi, Nobuhiko; Yasukawa, Masaki; Katayama, Naoyuki; Shiku, Hiroshi.

Blood ; 130(18): 1985-1994, 2017 11 02.

Artigo em Inglês | MEDLINE | ID: mdl-28860210

12.

[Adoptive therapy with TCR gene-modified T cells for hematological malignancies and solid tumors].

Ikeda, Hiroaki.

Rinsho Ketsueki ; 60(6): 716-722, 2019.

Artigo em Japonês | MEDLINE | ID: mdl-31281165

13.

MicroRNA-3662 expression correlates with antiviral drug resistance in adult T-cell leukemia/lymphoma cells.

Yasui, Kiyoshi; Izumida, Mai; Nakagawa, Takeya; Kubo, Yoshinao; Hayashi, Hideki; Ito, Takashi; Ikeda, Hiroaki; Matsuyama, Toshifumi.

Biochem Biophys Res Commun ; 501(4): 833-837, 2018 07 02.

Artigo em Inglês | MEDLINE | ID: mdl-29684346

14.

T-cell adoptive immunotherapy using tumor-infiltrating T cells and genetically engineered TCR-T cells.

Ikeda, Hiroaki.

Int Immunol ; 28(7): 349-53, 2016 07.

Artigo em Inglês | MEDLINE | ID: mdl-27127191

15.

Field-induced superconducting phase of FeSe in the BCS-BEC cross-over.

Kasahara, Shigeru; Watashige, Tatsuya; Hanaguri, Tetsuo; Kohsaka, Yuhki; Yamashita, Takuya; Shimoyama, Yusuke; Mizukami, Yuta; Endo, Ryota; Ikeda, Hiroaki; Aoyama, Kazushi; Terashima, Taichi; Uji, Shinya; Wolf, Thomas; von Löhneysen, Hilbert; Shibauchi, Takasada; Matsuda, Yuji.

Proc Natl Acad Sci U S A ; 111(46): 16309-13, 2014 Nov 18.

Artigo em Inglês | MEDLINE | ID: mdl-25378706

16.

[Cancer Immunotherapy Utilizing T Cell Receptor Gene Engineering].

Ikeda, Hiroaki.

Gan To Kagaku Ryoho ; 44(4): 273-277, 2017 Apr.

Artigo em Japonês | MEDLINE | ID: mdl-28428503

17.

Gene-modified T cell therapy.

Ikeda, Hiroaki.

Nihon Rinsho ; 75(2): 275-280, 2017 02.

Artigo em Japonês | MEDLINE | ID: mdl-30562864

18.

Exotic Multigap Structure in UPt_{3} Unveiled by a First-Principles Analysis.

Nomoto, Takuya; Ikeda, Hiroaki.

Phys Rev Lett ; 117(21): 217002, 2016 Nov 18.

Artigo em Inglês | MEDLINE | ID: mdl-27911558

19.

Omnidirectional Measurements of Angle-Resolved Heat Capacity for Complete Detection of Superconducting Gap Structure in the Heavy-Fermion Antiferromagnet UPd_{2}Al_{3}.

Shimizu, Yusei; Kittaka, Shunichiro; Sakakibara, Toshiro; Tsutsumi, Yasumasa; Nomoto, Takuya; Ikeda, Hiroaki; Machida, Kazushige; Homma, Yoshiya; Aoki, Dai.

Phys Rev Lett ; 117(3): 037001, 2016 Jul 15.

Artigo em Inglês | MEDLINE | ID: mdl-27472129

20.

Anomalous superfluid density in quantum critical superconductors.

Hashimoto, Kenichiro; Mizukami, Yuta; Katsumata, Ryo; Shishido, Hiroaki; Yamashita, Minoru; Ikeda, Hiroaki; Matsuda, Yuji; Schlueter, John A; Fletcher, Jonathan D; Carrington, Antony; Gnida, Daniel; Kaczorowski, Dariusz; Shibauchi, Takasada.

Proc Natl Acad Sci U S A ; 110(9): 3293-7, 2013 Feb 26.

Artigo em Inglês | MEDLINE | ID: mdl-23404698

Portal de Pesquisa da BVS Enfermagem

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar:

Teleocidin B-4, a PKC Activator, Upregulates Hypoxia-Inducible Factor 1 (HIF-1) Activity by Promoting the Accumulation of HIF-1α Protein via the PKCα/mTORC Signaling Pathway.

T cell receptor gene-modified allogeneic T cells with siRNA for endogenous T cell receptor induce efficient tumor regression without graft-versus-host disease.

Spin-Derived Electric Polarization and Chirality Density Inherent in Localized Electron Orbitals.

Current Concepts of Biomaterial Scaffolds and Regenerative Therapy for Spinal Cord Injury.

Prognostic significance of NY-ESO-1 antigen and PIGR expression in esophageal tumors of CHP-NY-ESO-1-vaccinated patients as adjuvant therapy.

Design, synthesis, and target identification of new hypoxia-inducible factor 1 (HIF-1) inhibitors containing 1-alkyl-1H-pyrazole-3-carboxamide moiety.

CD4⁺ T cells support polyfunctionality of cytotoxic CD8⁺ T cells with memory potential in immunological control of tumor.

First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors.

Antitumor activity of CAR-T cells targeting the intracellular oncoprotein WT1 can be enhanced by vaccination.

MAGE-A4, NY-ESO-1 and SAGE mRNA expression rates and co-expression relationships in solid tumours.

Safety and persistence of WT1-specific T-cell receptor gene-transduced lymphocytes in patients with AML and MDS.

[Adoptive therapy with TCR gene-modified T cells for hematological malignancies and solid tumors].

MicroRNA-3662 expression correlates with antiviral drug resistance in adult T-cell leukemia/lymphoma cells.

T-cell adoptive immunotherapy using tumor-infiltrating T cells and genetically engineered TCR-T cells.

Field-induced superconducting phase of FeSe in the BCS-BEC cross-over.

[Cancer Immunotherapy Utilizing T Cell Receptor Gene Engineering].

Gene-modified T cell therapy.

Exotic Multigap Structure in UPt_{3} Unveiled by a First-Principles Analysis.

Omnidirectional Measurements of Angle-Resolved Heat Capacity for Complete Detection of Superconducting Gap Structure in the Heavy-Fermion Antiferromagnet UPd_{2}Al_{3}.

Anomalous superfluid density in quantum critical superconductors.